About Aichi Cancer Center Hospital, Breast Oncology
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Aichi Cancer Center Hospital, Breast Oncology
During the past decade, Aichi Cancer Center Hospital, Breast Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
2008-09-01
2011-10-01
Completed
70
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aichi Cancer Center Hospital, Breast Oncology"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Aichi Cancer Center Hospital, Breast Oncology
According to Clinical.Site data, the most researched conditions in "Aichi Cancer Center Hospital, Breast Oncology" are
"Breast Cancer" (3 trials), "Gastric Cancer" (2 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Aichi Cancer Center Hospital, Breast Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Aichi Cancer Center Hospital, Breast Oncology
Most popular intervention types in "Aichi Cancer Center Hospital, Breast Oncology" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (4 trials), "Trastuzumab" (4 trials), "5-Fluorouracil" (3 trials), "Docetaxel" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Aichi Cancer Center Hospital, Breast Oncology
The vast majority of trials in "Aichi Cancer Center Hospital, Breast Oncology" are
6 trials for "All" genders.
Clinical Trials Status at Aichi Cancer Center Hospital, Breast Oncology
Currently, there are NaN active trials in "Aichi Cancer Center Hospital, Breast Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Aichi Cancer Center Hospital, Breast Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Aichi Cancer Center Hospital, Breast Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".